Switch to:

Regeneron Pharmaceuticals EV-to-Revenue

: 7.40 (As of Today)
View and export this data going back to 1991. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Regeneron Pharmaceuticals's enterprise value is $59,204 Mil. Regeneron Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $7,998 Mil. Therefore, Regeneron Pharmaceuticals's EV-to-Revenue for today is 7.40.

NAS:REGN' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.4   Med: 9.8   Max: 26.7
Current: 7.4
3.4
26.7

During the past 13 years, the highest EV-to-Revenue of Regeneron Pharmaceuticals was 26.70. The lowest was 3.40. And the median was 9.80.

NAS:REGN's EV-to-Revenue is ranked higher than
70% of the 864 Companies
in the Biotechnology industry.

( Industry Median: 19.05 vs. NAS:REGN: 7.40 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-09-24), Regeneron Pharmaceuticals's stock price is $565.19. Regeneron Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $69.36. Therefore, Regeneron Pharmaceuticals's PS Ratio for today is 8.15.

Regeneron Pharmaceuticals EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.68 7.89 6.77 5.75 5.43

Regeneron Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 4.08 5.43 6.75 8.15
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Regeneron Pharmaceuticals EV-to-Revenue Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's EV-to-Revenue falls into.


Regeneron Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Regeneron Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=59203.600/7998.1
=7.40

Regeneron Pharmaceuticals's current Enterprise Value is $59,204 Mil.
Regeneron Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 2048.4 (Sep. 2019 ) + 2169.5 (Dec. 2019 ) + 1828.2 (Mar. 2020 ) + 1952 (Jun. 2020 ) = $7,998 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Regeneron Pharmaceuticals  (NAS:REGN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Regeneron Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=565.19/69.358
=8.15

Regeneron Pharmaceuticals's share price for today is $565.19.
Regeneron Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 17.937 (Sep. 2019 ) + 18.981 (Dec. 2019 ) + 15.884 (Mar. 2020 ) + 16.556 (Jun. 2020 ) = $69.36.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Regeneron Pharmaceuticals EV-to-Revenue Related Terms

Regeneron Pharmaceuticals EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)